Among 520 IBD patients with a prior history of cancer, 62% were treated with thiopurines alone, 34% were treated with a combination of thiopurines and anti-TNF agents, and 4% were treated with anti-TNF agents alone. Here, TNF is linked to inflammatory bowel disease.